Cite Filings / PRME / 0001628280-23-017421

Feed Companies Filings Check

Sign in

DEFA14A

Proxy Materials

Prime Medicine, Inc. Filed 2023-05-11 Acc 0001628280-23-017421

Documents 1

DEFA14A Proxy Materials , defa14a51123.htm

Around this filing

2024-04-29 DEFA14A Proxy Materials
2023-05-11 10-Q Quarterly Report
2023-05-11 DEFA14A Proxy Materials
2023-05-11 8-K Executive or director change
2023-05-11 8-K Results of operations
2023-05-10 4 10% owner sold 422,010 shares at an average $14.09 ($5,946,340)
2023-04-28 DEFA14A Proxy Materials

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading defa14a51123.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…